Pro Medicus's Renewals Dispelling AI-Disruption Fears -- Market Talk

Dow Jones
Jun 04

0454 GMT - Pro Medicus's latest contract renewal shows that customers are expanding usage rather than cutting deal lengths, RBC analyst Jackson Lee says. Some investors had worried that customers of companies including the Australian medical-imaging tech provider would try to shorten contracts to preserve the option of switching to AI-driven alternatives. However, Lee writes in a note that the A$16 million renewal with Ohio State University Wexner Medical Center was for an unchanged five years. The center is also taking up new product modules, he adds. RBC has a last-published sector perform rating and a A$195.00 target price on the stock, which is down 0.6% at A$158.74. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

June 04, 2026 00:54 ET (04:54 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10